1,709
Views
4
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma

, MD, , PhD, MPH, , PhD, , MD, PhD & , MD
Pages 187-193 | Received 08 Apr 2015, Accepted 03 Jul 2015, Published online: 15 Sep 2015

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.